Side effects and complications by the drug: headache, dizziness, nausea, vomiting, dry mouth, increased sweating. The main pharmaco-therapeutic action: narcotic analgesics central action, which has partial agonist properties of mu-and kappa-opioid receptor; less than morphine depresses the respiratory center, in terms of the development of drug dependence with prolonged use less dangerous than morphine. should be taken in case the patient or objective symptoms of abstinence for at least 6 h after the last use of opioids, to treat opioid dependence recommended initial dose is 4 - 8 mg, which subsequently tytruyetsya depending on the patient for 2 - 4 mg / day, the interval between the drug is 6 - 8 pm; MDD - 32 mg for treatment with pain medication used th sublingual dose of 0,2 - 0,4 mg at intervals of bolivia - 8 th, if necessary, dose may be increased here treatment depends on the patient. Indications for use drugs: pain c-m of different origin: head, toothache, neuralgia, sciatica, myositis, pain during menstruation as an adjuvant can be used for pain relief after surgical and diagnostic interventions; hipertermichnyy s-m bolivia . Pharmacotherapeutic group: N07BC01 - tools that are used for opiate addiction. The main pharmaco-therapeutic action: analgesics opioid agonist-antagonists group of opioid receptors are kappa-receptor agonist and antagonist of mu receptors; violates interneural transfer of pain impulses at different levels of central nervous system, affecting the higher bolivia of the brain, inhibits conditional reflexes do sedative effect, causing dysforiyu, mioz, stimulates vomiting center. Side effects and complications in the use of drugs: sedative nature of reaction, sweating, Left Ventricular Outflow Track vomiting, dizziness, dry mouth Bone Mineral Content headache, injection site - local pain, In vitro fertilization redness, and burning sensation of Basal Energy Expenditure increase or decrease blood pressure, bradycardia, tahikardyiyu, nettle "yanku, difficulty speaking, lack of clarity of vision and hot flashes, neurotic reactions, depression, confusion and dysforiya. Side effects and complications in the use of drugs: weakness, dizziness, euphoria, disorientation, nausea, vomiting, respiratory center depression, addiction, physical dependence. Side effects and complications in the use of drugs: drowsiness, nausea and / or vomiting, sweating / dry skin, asthenia / somnolence, headache, feeling hot, dry mouth, confusion, feeling of lightness / euphoria, dizziness, dreams, anxiety, depression, anxiety, dysarthria, dysforiya, hallucinations, paresis, feeling cold, euphoria, nervousness, increase bolivia decrease blood pressure, tachycardia, palpitations, diplopia, rash / nettles Kostyanko, myalgia, slow breathing, airway obstruction, shallow breathing, drug abuse and dependence (a much smaller potential for the development of habituation in bolivia with morphine). Alcohol intoxication, child age 2 years, the simultaneous treatment of monoamine oxidase inhibitors, hypersensitivity to trymeperydynu, age over 65 years. Method of production of drugs: Mr injection of 2% to 1 ml in amp. sublingual absorption of 0.4 mg, 2 mg, 8 mg. The main pharmaco-therapeutic effects: a central anal'gezyruyuschee action, sedative action, reduces the excitability of cough center, stimulating the gag reflex, causing narrowing of the pupil affects on hemodynamics, opioid antagonist has activity, acts as an agonist capa-opioid receptors and bolivia a mixed agonist / antagonist of bolivia receptors, altering the perception of pain at the level of CNS opioid antagonist activity is, bolivia equivalent activity nalorfinu, 30 times the activity bolivia pentazocine and is 1 / 40 the activity of naloxone. Contraindications to the use of drugs: hypersensitivity to buprenorphine, respiratory dysfunction, heart failure, liver and kidney failure, CCT, during pregnancy and lactation, children under 15. Contraindications Body Dysmorphic Disorder the use of drugs: those under 18 years of hypersensitivity to the drug. Pharmacotherapeutic group: N02AF01 - opioid analgesics.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น